Marché mondial de la fluvoxamine – Tendances et prévisions de l’industrie jusqu’en 2029

Analyse et perspectives du marché : marché mondial de la fluvoxamine

Le marché de la fluvoxamine devrait connaître une croissance exponentielle au cours de la période de prévision 2022-2029. Data Bridge Market Research analyse le marché pour s'attendre à une croissance à un TCAC de 4 % au cours de la période de prévision mentionnée ci-dessus.

La fluvoxamine est un antidépresseur inhibiteur sélectif du recaptage de la sérotonine (ISRS). Ce médicament agit en augmentant le taux de sérotonine dans le cerveau. Il s'agit d'un médicament générique disponible sous deux formes, à savoir les comprimés et les capsules. Luvox et Luvox CR sont les noms commerciaux de ce médicament. Ce médicament est utilisé dans le traitement du trouble obsessionnel compulsif, de la dépression et du trouble de stress post-traumatique.

L’augmentation de la prévalence de l’anxiété et de la dépression constituera un moteur majeur de l’expansion du marché de la fluvoxamine. En outre, l’augmentation de la population gériatrique, l’augmentation des dépenses de santé et l’augmentation du nombre de patients souffrant de troubles obsessionnels compulsifs sont les facteurs qui développeront le marché de la fluvoxamine. D’autres facteurs, notamment l’augmentation de l’incidence croissante du trouble d’anxiété sociale, le changement de mode de vie et la sensibilisation croissante, auront un impact positif sur le taux de croissance du marché.

De plus, l’augmentation des activités de recherche et développement et les essais cliniques en cours offriront des opportunités bénéfiques pour le marché de la fluvoxamine au cours de la période de prévision 2021-2028.

Cependant, le coût élevé du médicament et les effets secondaires associés à la fluoxétine tels que la diarrhée, les maux de tête, l'indigestion, les nausées, la bouche sèche, les maux d'estomac, la perte de poids, les étourdissements, la fatigue et autres entraveront la croissance du marché. Le manque de sensibilisation constituera un défi supplémentaire pour le marché de la fluvoxamine au cours de la période de prévision mentionnée ci-dessus.

This fluvoxamine market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the fluvoxamine market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Fluvoxamine Market Scope and Market Size

The fluvoxamine market is segmented on the basis of drug class, application, demographic, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of drug class, the fluvoxamine market is segmented into antidepressant, selective serotonin reuptake inhibitor (SSRI) and others.
• On the basis of application, the fluvoxamine market is segmented into obsessive-compulsive disorder, depression, post-traumatic stress disorder and others.
• On the basis of demographic, the fluvoxamine market is segmented into adult, pediatric and geriatric.
• On the basis of dosage form, the fluvoxamine market is segmented into tablet, capsule and others. Tablet segment is further sub-segmented into 100mg, 25mg, and 50mg. Capsule segment is further sub-segmented into 100mg, and 150mg.
• On the basis of route of administration, the fluvoxamine market is segmented into oral and others.
• On the basis of end-users, the fluvoxamine market is segmented into clinic, hospital and others.

The fluvoxamine market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Fluvoxamine Market Country Level Analysis

Fluvoxamine market is analyzed and market size information is provided by the country, drug class, application, demographic, dosage form, route of administration, end-users and distribution channel as referenced above.

The countries covered in the fluvoxamine market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the fluvoxamine market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing research and development activities and rise in the prevalence of obsessive-compulsive disorder in this region.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Fluvoxamine market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Fluvoxamine Market Share Analysis

Fluvoxamine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to fluvoxamine market research.

Français Certains des principaux acteurs opérant sur le marché de la fluvoxamine sont Teva Pharmaceutical Industries Ltd., Abbott, Livzon, Solvay, Sun Pharmaceutical Industries Ltd., Novartis AG, Mylan NV, Merck KGaA, ., Apotex Inc., Bay Pharma GmbH, Synthon International Holding BV, TAIWAN BIOTECH CO., LTD., Shandong Octagon Chemicals Limited, Lake Chemicals Private Ltd., ZCL Chemicals Ltd., Ra Chem Pharma Ltd., RL Fine Chem Pvt. Ltd., et Mehta API Pvt Ltd., entre autres.

SKU-67395